ArticleEndocrinology, diabetes & metabolism2026
Dairy Intake and Type 2 Diabetes Mellitus in Iranian Older Adults: Insights From the Baseline Phase of the Birjand Longitudinal Aging Study.
Article in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a growing public health concern among older adults worldwide including in Iran. Despite extensive research on the metabolic effects of dairy products, their association with T2DM remains inconsistent, particularly in non-Western populations. This study examined the relationship between dairy consumption including specific types, and T2DM among older adults in eastern Iran.
methodsThis cross-sectional study utilised baseline data from the Birjand Longitudinal Aging Study (BLAS), which included community-dwelling adults aged 60 years and older. Dietary intake was assessed using structured questionnaires, and participants were categorised into tertiles based on dairy consumption (low, moderate, high). T2DM status was determined by FBS ≥ 126 mg/dL or a previous physician diagnosis. Logistic regression models estimated the odds ratios (ORs) and 95% confidence intervals (CIs) for T2DM across different levels of dairy intake, adjusting for potential confounders.
resultsData from 1348 participants were analysed, with an overall T2DM prevalence of 27.15%. Individuals in the highest tertiles of yogurt and cheese intake had significantly increased odds of T2DM (OR = 1.454, 95% CI = 1.08-2.20, p = 0.08; OR = 1.44, 95% CI = 1.04-2.00, p = 0.029). No significant association was found between milk consumption and T2DM risk. Total dairy consumption showed no significant association with T2DM in the fully adjusted model (OR = 1.42, 95% CI = 1.00-2.403, p = 0.05).
conclusionsThis study reveals a complex association between dairy intake and the risk of T2DM in Iran, in which high consumption of yogurt and cheese was paradoxically associated with increased odds of disease. This finding may be explained by the high fat content of these products, residual confounding from unmeasured dietary patterns, or biological pathways related to diabetes pathology and gut microbiota modulation that were not captured in our analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.